title: Targeted next-generation sequencing of familial platelet disorder with predisposition to acute myeloid leukaemia.
authors.affiliation: Cancer Molecular Diagnostics, St. James's Hospital, Dublin, Ireland. khaslam@stjames.ie.
authors.forename: Karl
authors.initials: K
authors.lastname: Haslam
authors.affiliation: Cancer Molecular Diagnostics, St. James's Hospital, Dublin, Ireland.
authors.forename: Stephen E
authors.initials: SE
authors.lastname: Langabeer
authors.affiliation: Department of Haematology, Galway University Hospital, Galway, Ireland.
authors.forename: Amjad
authors.initials: A
authors.lastname: Hayat
authors.affiliation: Department of Haematology, St. James's Hospital, Dublin, Ireland.
authors.forename: Eibhlin
authors.initials: E
authors.lastname: Conneally
authors.affiliation: Cancer Molecular Diagnostics, St. James's Hospital, Dublin, Ireland.|Department of Haematology, St. James's Hospital, Dublin, Ireland.
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Vandenberghe
mesh_terms: D000782:Aneuploidy; D001791:Blood Platelet Disorders / Q000235:genetics*; D004252:DNA Mutational Analysis; D005260:Female; D020022:Genetic Predisposition to Disease; D059014:High-Throughput Nucleotide Sequencing; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000473:pathology; D010375:Pedigree; D013921:Thrombocytopenia
keywords: FPD-AML; RUNX1; next-generation sequencing